This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

CardioMEMS Named As A Finalist For Intel Innovation Award

ATLANTA, Nov. 16, 2012 /PRNewswire/ -- CardioMEMS has been named as one of four finalists for the prestigious Intel Innovation Award, a part of the 2012 Health IT Leadership Summit ( www.HealthITLeadershipSummit.org) that will take place on December 4, 2012 at the historic Fox Theatre. This is the second year for the award, which recognizes companies developing leading-edge technology and unique approaches to improving health, as well as healthcare delivery and processes.

CardioMEMS is a medical device company that has developed and is commercializing proprietary wireless sensing and communication technology for the human body. The company's technology platform is designed to improve the management of severe chronic cardiovascular diseases such as aneurysms, heart failure, and hypertension. CardioMEMS miniature wireless sensors can be implanted using minimally invasive techniques and transmit cardiac output, blood pressure and heart rate data, which are critical to the management of patients. The sensors are designed to be permanently implanted into the heart and blood vessels due to their small size, durability and lack of wires and batteries. The sensors transmit real-time data to external electronic readers, which then communicate this information to the patient's physician through a secure web portal. CardioMEMS developed this technology based on the belief that frequent, on-demand, real-time monitoring of vital information enables proactive patient management, which holds the promise of reducing hospitalizations, improving a patient's quality of life and delivering more efficient and cost effective health care. More information about CardioMEMS is located at www.cardiomems.com.

"We are excited and honored to be a finalist for the Intel Innovation Award," said CardioMEMS Founder and CEO, Jay Yadav, M.D.  "CardioMEMS has benefited significantly from the important entrepreneurial support system that TAG and the Metro Atlanta Chamber provide.  Atlanta's position as the nation's health IT capital, coupled with Georgia's excellent University System, has afforded us access to a tremendous talent pool, enabling creation of this groundbreaking technology."

"The companies that have been named finalists should be very proud. It's a tremendous honor," said David Hartnett, Vice President Economic Development, Bioscience-Health IT, Metro Atlanta Chamber. "This level of innovation is representative of the technologies and advancements being made here in Atlanta, the nation's health IT capital."

"Given the number of quality nominations, it has been a difficult process for the judges," said Wayne Myers, chairman for the 2012 Summit. "We saw very diverse examples of technology and marketplace innovation, each making a positive impact in regards to the challenges facing the health industry."

The impact of innovation on healthcare is a cornerstone of the Summit, which will feature two panel discussions focusing specifically on the topic. "Innovation: Improving Cost and Quality" covers the application of technology, analytics and automation to improve the cost and quality of care; and "Innovative Approaches" looks at how landmark programs are leveraging innovative technology to improve access to quality care, particularly for rural areas most in need.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,729.70 -75.01 -0.45%
S&P 500 1,934.38 -11.78 -0.61%
NASDAQ 4,390.47 -31.6150 -0.71%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs